A Phase Ib, Multicenter, Open-Label Study of Multiple-Dose EA5 in Adults With Paroxysmal Nocturnal Hemoglobinuria (PNH)
Clinical trial NCT07256301 · RECRUITING
Trial details
- NCT number
- NCT07256301
- Sponsor
- Shanghai Lanyi Therapeutics Co., Ltd.
- Status
- RECRUITING
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2024-01-03
- Primary completion
- 2026-08-31
- Enrollment
- 24
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.